{"name":"Newleos Therapeutics, Inc.","slug":"newleos-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPWnZaZ3Z6bEQ4WW95a283V1dUMHgxLWlDekVmOURNd19pOGxJMENSOTVjNDdOTXlJUU9BRGlNcjUtT285MWEtWWVzbmFfRTlUVXdBUXg1WHkwRV9Vb1J0OGxHNmtfZUhjWUFXb2RsZzdhWXBmQUYxRE1ZM1BldS01N01pR0dBOW1mWTdtZEFqd0N6R21NTGozRHp2RDFIWlJ4RDBKOUVGbjlzZw?oc=5","date":"2025-10-21","type":"pipeline","source":"Contract Pharma","summary":"Newleos Therapeutics Appoints Timothy Noyes as President & CEO - Contract Pharma","headline":"Newleos Therapeutics Appoints Timothy Noyes as President & CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNcFdDd0RYbHpGREJTZHZtaEJoZlB5aktZM1ZKdG5JSGd6RVRvR2RUUHdyblpIWk9wNzBON2JYODVfXzRmYVZyems5Rm10WDkzYkZJNWNlUTBveThsaUtRSFpmLWdZcWJtajdqTEh4UFJ3dnBualdpODFObEpBOE9SRFRla0kzTnMtalhWcjZ3SXJKdEUwcUlHbFRuUWd1dXZJVUZOc0licGdVeENIcjJucU54Q0hMVjZvakgwRzJFZVFEdw?oc=5","date":"2025-10-21","type":"pipeline","source":"BioSpace","summary":"Newleos Therapeutics Appoints Timothy Noyes as President and Chief Executive Officer - BioSpace","headline":"Newleos Therapeutics Appoints Timothy Noyes as President and Chief Executive Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxPbnhjR2JXVHFPa2luc2JHUzZvWFI4NHZkSmVHZnQ3aDFYazBVRmpNVl96cHlhcHdxMFBLSWFpVURWWVRMRDBkNE9MSzJJRE1TcjdVMHB2aThXeGZnbFFoYTktZm1Ub2NRVHJVekliR2JYSUhwczdMMXAzMlZ2VnptdzZhdUw5QXg1SFJnQmVPX01WQUxodHRRQkN6ZU56Z2FUcFQzQzhlT1ZwQk80dURTQ3RRTUJDd2ktWm1fU0dNUlNJVUwxaXN5NFBjRDdZM0FDdm9xVzhPVUNQaHhmOE9pcGpMejhFWnhuOHBFWGhCOC1iVVRWbTZzNnFtMkVuWEgteTdDRzdTR0ZoZi1OQlpoZUNB?oc=5","date":"2025-04-08","type":"pipeline","source":"businesswire.com","summary":"Newleos Therapeutics Expands Leadership Team to Advance its Clinical-Stage Neuropsychiatric Programs and Drive Corporate Growth - businesswire.com","headline":"Newleos Therapeutics Expands Leadership Team to Advance its Clinical-Stage Neuropsychiatric Programs and Drive Corporate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPd190SWc5WFF5b0Fob1o0TFdlcHI4bHVveHUwNWdQYVJ0RzBWR2x0cUVzN1NhZHNWR3AyUnl0VjQyWkJ4b0Z4VzhxMEFjTlIyRlN5ZUZFQ3BiMkhNb3UxUHFBdERWektEZFNVREp4ZHBlemwxTnhGRzNBWlE2TGZ3T3pxTHljYzhPbFpwT2tlcGZzQQ?oc=5","date":"2025-02-14","type":"pipeline","source":"Pharmaceutical Technology","summary":"Newleos secures $93.5m for neuropsychiatric disorder treatments - Pharmaceutical Technology","headline":"Newleos secures $93.5m for neuropsychiatric disorder treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPVTJabmEwR2g5a0VBVWREVFRzZllob0lVcHQzRHdQUm93MWlBR1JLMmhNeXZGRThIUGI4YXkwSno4bGdmeGFDVTBUOWEwSHBUeUdjVWZsZElVOU50VkRPejZQNDZCSnpPMnRScnlQLXlBX3RNUnVKSThPQ2pud0JQWE1ZbzdCa014NWZGRnVyYTlvcWtVYk55Y2wxVXFBZTJtVkk2V0d3?oc=5","date":"2025-02-13","type":"pipeline","source":"BioSpace","summary":"Newleos Raises $93.5M to Advance Neuropsychiatric Cast-Offs from Roche - BioSpace","headline":"Newleos Raises $93.5M to Advance Neuropsychiatric Cast-Offs from Roche","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPNHdYeUJvUlRVTUpLX1V5cWdmMzhfMGZwYVFKNWUwa3NzcmFsaGstUzJFTjQzeDBlVld5RnVGLTlWZFV4RWozT1Jib1VsMWRLUDJaS0ozYVc1MjRadnEyTVB6cGFNSHBHanYyT283ZTE5THhGX0FFRnJjdnpWUlRDZmZrOU8tYnFnLXgzd3RiMWd1Y0RWdnJpT21QV2VJa1N4?oc=5","date":"2025-02-13","type":"deal","source":"Fierce Biotech","summary":"VC Longwood Fund unveils neuro biotech with $93M, assets licensed from Roche - Fierce Biotech","headline":"VC Longwood Fund unveils neuro biotech with $93M, assets licensed from Roche","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE1EZTVMZ29QQVBZUDR1NEJrV3ZlVF9lOEM3REIyUGdEOXFjRk5Tb0pRY0tIaHRIbWxpbFVUdnhyZ1hPSzRCUEpndmVEcXZUTmNSNTZBSWlpczlYendnaVJxV1NR?oc=5","date":"2025-02-13","type":"pipeline","source":"The Pharma Letter","summary":"Newleos Therapeutics - The Pharma Letter","headline":"Newleos Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxOZUxCMmJiUVNCRlNNNEdsTzJKaGp6VndHVjAtTThCbmtiTzR0RFlYcnRIWjQxUmY2Z1NUTmplY1puWHNvcDBhb0RSUkpxMWhQQTgyUk9uRklIa1ZfZE0tNzJTNDJOQlF4YnlVXzVLc29iQXduQ2JPcWUxOGR1TGw4TTVpTEI1Y3FxZ2c?oc=5","date":"2025-02-13","type":"pipeline","source":"BioPharma Dive","summary":"A brain biotech launches with Roche’s spare parts - BioPharma Dive","headline":"A brain biotech launches with Roche’s spare parts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wJBVV95cUxQdV9CeU0zcEZISzB0dXZVa0JjSkZsaU45M0d6WUl2N2tNZXE4Q2lfaDJucENWMHpRMElVZzZJajMxcjlWLTczVW9QS3pfV2JuNlpGM2JlYk1hOU42TmlJSW45NFVJRGtZZ2xIajc2QV9qeTYzVG9tdmNELU84bm0tdERMZkhCTTZPc0FGSC1aU0lGanoteHR3cXVtdHo3bHlKbWRieW1ZcTBfVkE3MEwyQjNsOXhRZkRCQlFIaVJyRFl1Z2pldnRrU0JKMDVqMzktejBaSWx5b3h3eXY1MEFnVkR0czJKeENvVkQxQVU2ZTNXajhrdUhqQ1RCd21xZVg0NE5yTDhQemVCTEM3SlJpX2Jjb1pvVkdTcHpKM18zTmFNSkthQng0U2NjbTRCdFl4eWYtNXZPcEVSdHNnN2NDdjNYLVUwNVBXQjFPdHR4b01EaDdoWGRpQy1lRQ?oc=5","date":"2025-02-13","type":"pipeline","source":"businesswire.com","summary":"Newleos Therapeutics Debuts with $93.5 Million Oversubscribed Series A Financing to Transform the Treatment of Neuropsychiatric Disorders through the Advancement of Novel Medicines - businesswire.com","headline":"Newleos Therapeutics Debuts with $93.5 Million Oversubscribed Series A Financing to Transform the Treatment of Neuropsyc","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}